Mannkind (MNKD) Gross Margin Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7,249.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -191.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -33.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -480.00 |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 2,443.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,443.00 |
| Dec 31, 2025 | -8,492.00 |
| Sep 30, 2025 | 3,578.00 |
| Jun 30, 2025 | 153,298.00 |
| Mar 31, 2025 | 10,133.00 |
| Dec 31, 2024 | 25,734.00 |
| Sep 30, 2024 | 1,260.00 |
| Jun 30, 2024 | 1,120.00 |
| Mar 31, 2024 | 1,898.00 |
| Dec 31, 2023 | 5,382.00 |
| Sep 30, 2023 | -283.00 |
| Jun 30, 2023 | 180,970.00 |
| Mar 31, 2023 | -711.00 |
| Dec 31, 2022 | 10,144.00 |
| Sep 30, 2022 | 97,289.00 |
| Jun 30, 2022 | 62,450.00 |
| Mar 31, 2022 | -8,310.00 |
| Dec 31, 2021 | -23,250.00 |
| Sep 30, 2021 | 10,150.00 |
| Jun 30, 2021 | 11,193.00 |
| Mar 31, 2021 | 9,092.00 |
| Dec 31, 2020 | 9,097.00 |
| Sep 30, 2020 | 20,054.00 |
| Jun 30, 2020 | -160,336.00 |
| Mar 31, 2020 | 5,903.00 |
| Dec 31, 2019 | 497.00 |
| Sep 30, 2019 | -101,144.00 |